MST1R and cancer: To investigate whether the different glycosylation displayed by our cell lines had an effect on the capacity of cells to respond to cancer drugs, we evaluated the GC cell models under 3D culture systems and subjected these gastric MCTS to the TKI crizotinib, a drug described to target the RTKs MET and RON.